Cost of Vumerity in 2025: Discounts and Additional Benefits
Brand-Name Drug Vumerity: Costs and Comparisons
Vumerity, a brand-name oral delayed-release capsule, is approved for treating adults with relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting MS, and active secondary progressive MS [1]. However, its cost can vary based on factors such as treatment plan, insurance coverage, pharmacy used, and whether Vumerity has a savings program [2].
Generics tend to cost less than brand-name drugs due to reduced research and development costs and market competition. In contrast, Vumerity is only available as a brand-name drug and does not have a generic version [3]. This difference in cost is primarily due to the expenses incurred by brand-name manufacturers for research, development, marketing, and patent protection [4].
Brand-name companies invest heavily in discovering and proving the safety and efficacy of new drugs, expenses that generic manufacturers do not incur because they rely on existing data once the patent expires [4]. Additionally, brand-name drugs carry significant expenditures on advertising and promotion to build brand awareness, which generics usually avoid, reducing their price [4].
Patents grant exclusivity, allowing brand-name drugs to be sold without competition and thus at higher prices [5]. However, it's important to note that generic drugs like generic versions of Vumerity are demonstrated to be bioequivalent to brand-name drugs, meaning they have the same active ingredient, dosage, strength, route of administration, and therapeutic effect [6].
The cost comparison between Vumerity and other MS treatments, such as Tecfidera, depends on factors such as treatment length, insurance coverage, and payment assistance programs. For details about Vumerity's side effects, see the article on Vumerity's side effects or the Vumerity prescribing information [1].
Insurance companies may require prior authorization for Vumerity before covering it. Financial and insurance assistance programs are available for Vumerity, such as Biogen Support Services and resources like the Medicine Assistance Tool and NeedyMeds [7].
For more information about multiple sclerosis (MS), see the MS hub and list of MS articles [8]. To learn about Medicare coverage for drugs, see articles about Medicare prescription drug plans, drug coupons and Medicare, and the Medicare drug list [9].
For details about other aspects of Vumerity, refer to the article on Vumerity [1]. For details about Vumerity's dosage, view the article on Vumerity and dosage [10].
References:
- [Vumerity (diroximel fumarate) capsules, for oral use] (https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208548s000,208659s000,208660s000lbl.pdf)
- [Vumerity: Medication Guide] (https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208548s000,208659s000,208660s000mg.pdf)
- [Generic Drugs: What They Are and How They Work] (https://www.fda.gov/consumers/consumer-updates/generic-drugs-what-they-are-and-how-they-work)
- [Why Generic Drugs Cost Less] (https://www.fda.gov/consumers/consumer-updates/why-generic-drugs-cost-less)
- [How Generic Drugs Save Money and Lives] (https://www.fda.gov/for-industry/generic-drugs/how-generic-drugs-save-money-and-lives)
- [FDA Approves First Generic of Biogen's Tecfidera for Multiple Sclerosis] (https://www.fda.gov/news-events/press-announcements/fda-approves-first-generic-biogens-tecfidera-multiple-sclerosis)
- [Biogen Support Services] (https://www.biogen.com/patients/financial-assistance)
- [Multiple Sclerosis (MS)] (https://www.msrc.co.uk/)
- [Medicare Prescription Drug Plans] (https://www.medicare.gov/prescription-drug-coverage/)
- [Vumerity and Dosage] (https://www.msrc.co.uk/articles/vumerity-and-dosage)
